Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)

Clinical Trial ID NCT00508001

PubWeight™ 7.14‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00508001

Top papers

Rank Title Journal Year PubWeight™‹?›
1 HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol 2011 2.10
2 The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 2010 2.07
3 Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget 2012 1.55
4 Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future. Oncotarget 2010 0.84
5 Targeted therapies in the treatment of advanced hepatocellular carcinoma. Clin Med Insights Oncol 2013 0.83
Next 100